More babies born at Leicester’s hospitals are dying in their first month of life than at comparable trusts, a national ...

KUWAIT: Families waited eagerly outside public schools across Kuwait on Sunday and Monday, ready to welcome high schoolers walking out of their final exams from the art and science streams. Cars ...

Is SLS a good stock to buy? We came across a bullish thesis on SELLAS Life Sciences Group, Inc. on BioEquity Watch’s Substack ...

Summer 2026 is shaping up to be one of the strongest anime seasons in recent years. The schedule brings together blockbuster ...

The first randomized, controlled trial for a common childhood eating disorder has shown how therapists and parents can help ...

Unpopular REIT sectors may offer the biggest upside—life science turnarounds and timberland catalysts. Click here to discover ...

Acquisition adds YUPELRI ® (revefenacin), the first and only approved nebulized long-acting muscarinic antagonist (LAMA) for the maintenance treatment of COPD to Zymeworks' portfolio Acquisition of ...

Investor interest has focused on companies nearing key milestones, signing major partnerships, or improving their business ...